Bryndis Birnir

Member, Scientific Advisory Board at Diamyd Medical AB

Bryndis Birnir

Bryndis Birnir

Member, Scientific Advisory Board at Diamyd Medical AB

Biography

Professor Bryndis Birnir
Uppsala University, Uppsala, Sweden. Department of Neuroscience.

Professor of Physiology within the Medical Faculty at Uppsala University. Professor Birnir’s research is focused on GABA signaling and the interplay between the extracellular signal molecule GABA and the high-affinity GABA-A receptors that are ion channels. The study of how these molecules affect secretion of metabolic hormones, cellular excitability and immune modulation shows how processes are of vital importance for many metabolic and inflammatory diseases like diabetes. Professor Birnir has been a member of the Scientific and Medical Advisory Board since 2013.

Overview
RelSci Relationships

20

Number of Boards

1

Relationships
RelSci Relationships are individuals Bryndis Birnir likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Chief Executive Officer at Essen-Möller Consulting

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Professor, Departments of Pathology & Pediatrics at University of Florida

Relationship likelihood: Average

Director, Business Development at NextCell Pharma AB

Relationship likelihood: Average

Chairman at Blasieholmen Investment Group Seed AB

Relationship likelihood: Average

Paths to Bryndis Birnir
Potential Connections via
Relationship Science
You
Bryndis Birnir
Member, Scientific Advisory Board at Diamyd Medical AB
Boards & Committees
Member, Scientific Advisory Board
Current

Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. It also develops and invests in stem cell and medical technology. The company was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bryndis Birnir. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bryndis Birnir's profile does not indicate a business or promotional relationship of any kind between RelSci and Bryndis Birnir.